Cubist Systematic Strategies’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Buy |
+239,959
| New | +$343K | ﹤0.01% | 1121 |
|
|
2025
Q1 | – | Sell |
-109,825
| Closed | -$395K | – | 1554 |
|
|
2024
Q4 | $395K | Buy |
109,825
+6,799
| +7% | +$24.5K | ﹤0.01% | 1040 |
|
|
2024
Q3 | $587K | Sell |
103,026
-457,933
| -82% | -$2.61M | ﹤0.01% | 952 |
|
|
2024
Q2 | $2.59M | Sell |
560,959
-203,903
| -27% | -$942K | 0.02% | 503 |
|
|
2024
Q1 | $6.25M | Buy |
764,862
+453,485
| +146% | +$3.7M | 0.04% | 420 |
|
|
2023
Q4 | $1.76M | Buy |
311,377
+243,230
| +357% | +$1.37M | 0.01% | 882 |
|
|
2023
Q3 | $127K | Sell |
68,147
-177,055
| -72% | -$329K | ﹤0.01% | 1602 |
|
|
2023
Q2 | $674K | Buy |
245,202
+230,642
| +1,584% | +$634K | ﹤0.01% | 1303 |
|
|
2023
Q1 | $45.7K | Sell |
14,560
-30,540
| -68% | -$95.9K | ﹤0.01% | 2538 |
|
|
2022
Q4 | $266K | Sell |
45,100
-40,808
| -48% | -$241K | ﹤0.01% | 2514 |
|
|
2022
Q3 | $753K | Sell |
85,908
-35,310
| -29% | -$309K | ﹤0.01% | 2253 |
|
|
2022
Q2 | $914K | Buy |
121,218
+82,194
| +211% | +$620K | 0.01% | 2174 |
|
|
2022
Q1 | $947K | Buy |
39,024
+5,027
| +15% | +$122K | 0.01% | 2065 |
|
|
2021
Q4 | $1.1M | Sell |
33,997
-3,303
| -9% | -$106K | 0.01% | 1846 |
|
|
2021
Q3 | $1.67M | Buy |
37,300
+27,567
| +283% | +$1.23M | 0.02% | 1153 |
|
|
2021
Q2 | $368K | Buy |
+9,733
| New | +$368K | ﹤0.01% | 2205 |
|
|
2021
Q1 | – | Sell |
-19,994
| Closed | -$662K | – | 2844 |
|
|
2020
Q4 | $662K | Buy |
+19,994
| New | +$662K | 0.01% | 1622 |
|